Welcome to Plenary Session.

I'm your host, Dr. Vinay Prasad.

I'm a practicing hematologist, oncologist, and I'm associate professor of medicine.

I'm interested in issues at the intersection of medicine, oncology, and health policy, and that's what you're going to get on this podcast.

Welcome to Season 2.

This week on Plenary Session, we've got a few things in store for you.

First, I'm going to be discussing a new paper by Alison Haslam, which is entitled Patient Experience

Captured by Quality of Life Measurement in Oncology Clinical Trials.

This came out in

JAMA Network open on March 4th and it's a fascinating little slice of quality of life

literature. You won't want to miss it. And I also have a discussion of March 2nd's paper. Overall

survival in patients with pancreatic cancer receiving matched therapies following

molecular profile, a retrospective analysis of the know-your-tumor-tumor registry trial.

This came out in the Lancet Oncology, and this is just a great example of how to produce

the least useful and most worthless document that could ever be put in a peer-reviewed literature.

You won't want to miss this discussion, so stay tuned.

But first, a thanks. I want to thank those of you who've gone online and support this

podcast on patreon.com. Patreon subscribers get access to the slides from lectures I give on plenary session.

I also want to thank the hundreds of you who've gone to the iTunes store and reviewed this podcast. We appreciate that feedback. I also want to thank the hundreds of you who've gone to the iTunes store and

reviewed this podcast. We appreciate that feedback. I also want to thank the dozens of you who've

written reviews. A written review goes a long way. What can plenary session do for you? Email us your

questions at plenary session podcast at gmail.com. Tweet to us at Plenary underscore Session.

...